跳至主要内容
临床试验/NCT00224432
NCT00224432已完成不适用

Double-Blind, Parallel, Randomised Study to Investigate the Clinical and Immunological Effects of Oral Administration of Probiotic Bacteria in Infants With Atopic Dermatitis With and Without Cow's Milk Allergy.

Groningen Research Institute for Asthma and COPD2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2001年3月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
2
主要终点
Significant decrease of SCORAD score in treated infants compared to placebo

研究概览

简要总结

To study the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological parameters in infants with AD with and without CMA and to compare effectiveness of different strains of probiotics.

详细描述

  • To determine the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological parameters in infants with AD with and without CMA
  • To determine the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological reactivity to cow' milk challenge in infants with AD with CMA
  • To compare the effectiveness of different strains of probiotic bacteria in improving clinical and immunological outcome in these infants

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
0 Years 至 5 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Term infants fulfilling the Hanifin (1989) criteria for atopic dermatitis
  • Suggestive of CMA (one additional symptom)
  • Scorad index (total) >20 at study entry
  • Below 5 months of age
  • Formula, not breast fed
  • Written informed consent from the parents

排除标准

  • • Previous or current use of anti-histamines, oral corticosteroids, probiotics
  • Use of systemic antibiotic or anti-mycotic drugs in the previous 4 weeks
  • Congenital intestinal abnormality (eg. Hirschsprung's disease, intestinal atresia)
  • Other GI disease with intestinal inflammation and/or increased intestinal permeability
  • Skin disorder, not atopic dermatitis
  • Participation in another clinical study

结局指标

主要结局

Significant decrease of SCORAD score in treated infants compared to placebo

次要结局

  • IL-4, IL-5 and IFN-gamma production of stimulated peripheral blood mononuclear cells
  • change in fecal TNF-α and α-1-antitrypsin, urinary EDN
  • effect on faecal bacteria after probiotics

研究者

发起方
Groningen Research Institute for Asthma and COPD
申办方类型
Other

研究点 (2)

Loading locations...

相似试验